Neuropsychiatric Research Databases for People With Intellectual Disabilities and Epilepsy (REFINE)
NCT ID: NCT06780501
Last Updated: 2025-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2024-09-12
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Part One: De-identified Database
The goal of this part is to establish a research database containing de-identified data about People with Intellectual Disabilities (PwID) and epilepsy, collected from three NHS sites across England and Wales. Researchers will gather information from participants' medical records, including clinical details, epilepsy history, and medications, and will enter this data into a secure database where all identifying details are removed. This part of the study aims to determine whether it's possible to identify eligible participants, collect complete datasets for each participant, and identify any issues that may affect the quantity and quality of data. These findings will help inform a potential future study that could involve 20 or more sites.
Part Two: Research Register
The goal of this part is to create a research register of individuals with PwID and epilepsy. Participants will be approached and asked for their consent to collect their personal and clinical data, which will help identify those willing to take part in future ethically approved research projects. As in Part One, researchers will collect data from medical records. Participants who consent to be included in the register may be contacted by external researchers for future studies. The aim is to facilitate national collaboration by enabling data sharing between research projects, thereby improving the ability to answer more questions and enhance patient care. This part of the study will test whether it's possible to determine screening and recruitment rates at each site, develop and evaluate recruitment processes, and assess how researchers leading other approved studies can obtain permission to use the register. Additionally, it will evaluate whether it's possible to collect a complete dataset for each participant.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy
NCT01212068
Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders
NCT05212727
Study of Brain Anatomo-functional Substrates Related to the Use of Human Tool by Means of Simultaneous Acquisition of Magnetic Resonance Imaging and Electroencephalogram
NCT05767489
An Examination of Cognitive and Sensorimotor Processes in Patients With Epilepsy
NCT00859794
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
NCT05559060
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of epilepsy in medical records.
* Patient is over the age of 18 years old.
* Under the current care of specialist ID or epilepsy services at one of the three participating NHS Trusts.
* Clinical diagnosis of ID in medical records.
* Clinical diagnosis of epilepsy in medical records.
* Under the current care of specialist ID or epilepsy services at one of the three participating NHS Trusts.
* Between the ages of 18 and 30 at the time of consent.
* Participant has the capacity to be able to provide consent for themselves, or a personal consultee is able to provide an opinion on the views and feelings of the potential participant.
* Patients (or personal consultee) must be able to communicate in English (or Welsh in Welsh site).
Exclusion Criteria
* Patient is recorded on the National Data Opt-out as not wishing their data to be used for research/audit.
The research register:
\- Other neurodevelopmental disorders without ID.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Plymouth
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Rohit Shankar
Professor in Neuropsychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lance Watkins
Role: PRINCIPAL_INVESTIGATOR
Swansea Bay University Health Board
Sarah Lennard
Role: PRINCIPAL_INVESTIGATOR
Cornwall Partnership NHS Foundation Trust
Heather Angus-Leppan
Role: PRINCIPAL_INVESTIGATOR
Royal Free London NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cornwall Partnership NHS Foundation Trust
Bodmin, , United Kingdom
Royal Free London Hospitals NHS Trust
London, , United Kingdom
Swansea Bay University Health Board
Swansea, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sarah Lennard
Role: primary
Heather Angus-Leppan
Role: primary
Lance Watkins
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5284
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.